SereNeuro Therapeutics

SereNeuro Therapeutics is developing non-opioid cell and gene therapies to address the need for effective and safe treatments for chronic pain. SereNeuro uses mature and purifiable subsets of induced pluripotent stem cell-derived sensory neurons (iPSC-SNs) to decipher the functional heterogeneity of human pain perception and develop targeted therapies. This approach not only aims to provide pain relief but also promotes bone regeneration, offering a disease-modifying solution to chronic pain management.